Association between polymorphisms in glutathione S-transferase Mu3 and IgG titer levels in serum against Helicobacter pylori

Journal of Human Genetics

Volumn 54, Issue 10, 2009, Pages 557-563

  Tatemichi, Masayuki ^a,b   Iwasaki, Motoki ^b   Sasazuki, Shizuka ^b   Tsugane, Shoichiro ^b  

^a SHOWA UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER   (Japan)

Author keywords

GST Mu3; Helicobacter pylori; IgG titer; Polymorphism

Indexed keywords

CAGA PROTEIN; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M2; GLUTATHIONE TRANSFERASE M3; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T2; IMMUNOGLOBULIN G; MEMBRANE ANTIGEN; PEPSINOGEN I; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ALLELE; ANTIBODY TITER; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ANTIBODY FORMATION; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN G; LINKAGE (GENETICS); MALE; MIDDLE AGED; PEPSINOGEN A; POLYMORPHISM, SINGLE NUCLEOTIDE;

HELICOBACTER PYLORI;

EID: 70350464739     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2009.77     Document Type: Article

References (40)

1. Chey, W. D. & Wong, B. C. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am. J. Gastroenterol. 102, 1808-1825 (2007).
2. Megraud, F., O'Morain, C., Bazzoli, F., El-Omar, E., Graham, D. et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 56, 772-781 (2007). (Pubitemid 46854190)
3. Correa, P. Does Helicobacter pylori cause gastric cancer via oxidative stress? Biol. Chem. 387, 361-364 (2006).
4. Ketterer, B. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat. Res. 202, 343-361 (1988).
5. Boccia, S., La Torre, G., Gianfagna, F., Mannocci, A. & Ricciardi, G. Glutathione S-transferase T1 status and gastric cancer risk: a meta-analysis of the literature. Mutagenesis. 21, 115-123 (2006).
6. Hayes, J. D., Flanagan, J. U. & Jowsey, I. R. Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 45, 51-88 (2005).
7. Blecker, U., Lanciers, S., Hauser, B., Mehta, D. I. & Vandenplas, Y. Serology as a valid screening test for Helicobacter pylori infection in asymptomatic subjects. Arch. Pathol. Lab. Med. 119, 30-32 (1995).
8. Tatemichi, M., Kabuto, M. & Tsugane, S. Effect of smoking on serum pepsinogen I level depends on serological status of Helicobacter pylori. Jpn. J. Cancer. Res. 92, 243-248 (2001).
9. Koizumi, W., Tanabe, S., Imaizumi, H., Hibi, K., Kida, M., Ohida, M. et al. Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection. Hepatogastroenterology 50, 293-296 (2003).
10. Suzuki, G., Cullings, H., Fujiwara, S., Hattori, N., Matsuura, S., Hakoda, M. et al. Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori. Cancer Epidemiol. Biomarkers Prev. 16, 1224-1228 (2007).
11. Tatemichi, M., Hamada, G. S., Nishimoto, I. N., Kowalski, L. P., Iriya, K., Rodrigues, J. J. et al. Ethnic difference in serology of Helicobacter pylori CagA between Japanese and non-Japanese Brazilians for non-cardia gastric cancer. Cancer Sci. 94, 64-69 (2003).
12. Maeda, S., Yoshida, H., Ogura, K., Yamaji, Y., Ikenoue, T., Mitsushima, T. et al. Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs. Cancer 88, 1530-1535 (2000).
13. Tatemichi, M., Sasazuki, S., Inoue, M. & Tsugane, S. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen. Acta. Oncol. 47, 360-365 (2008).
14. Hamajima, N., Naito, M., Kondo, T. & Goto, Y. Genetic factors involved in the development of Helicobacter pylori-related gastric cancer. Cancer Sci. 97, 1129-1138 (2006).
15. Ikeda, S., Sasazuki, S., Natsukawa, S., Shaura, K., Koizumi, Y., Kasuga, Y. et al. Screening of 214 single nucleotide polymorphisms in 44 candidate cancer susceptibility genes: a case-control study on gastric and colorectal cancers in the Japanese population. Am. J. Gastroenterol. 103, 1476-1487 (2008).
16. Maes, O. C., Schipper, H. M., Chong, G., Chertkow, H. M. & Wang, E. A GSTM3 polymorphism associated with an etiopathogenetic mechanism in Alzheimer disease. Neurobiol. Aging (2009) (in press).
17. Tetlow, N., Robinson, A., Mantle, T. & Board, P. Polymorphism of human mu class glutathione transferases. Pharmacogenetics 14, 359-368 (2004). (Pubitemid 38813690)
18. Liu, X., Campbell, M. R., Pittman, G. S., Faulkner, E. C., Watson, M. A. & Bell, D. A. Expression-based discovery of variation in the human glutathione S-transferase M3 promoter and functional analysis in a glioma cell line using allele-specific chromatin immunoprecipitation. Cancer Res. 65, 99-104 (2005).
19. Miki, K. & Urita, Y. Using serum pepsinogens wisely in a clinical practice. J. Dig. Dis. 8, 8-14 (2007).
20. Huang, S. C., Miki, K., Hirano, K., Hayashi, Y., Furihata, C., Shimizu, A. et al. Enzyme-linked immunosorbent assay of serum pepsinogen I. Clin. Chim. Acta. 162, 85-96 (1987).
21. Onoda, N., Katsuragi, K., Maeda, K., Sawada, T., Wakasa, K. & Hirakawa, K. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery. Hepatogastroenterology 53, 619-623 (2006).
22. Hong, G. S., Heun, R., Jessen, F., Popp, J., Hentschel, F., Kelemen, P. et al. Gene variations in GSTM3 are a risk factor for Alzheimer's disease. Neurobiol. Aging 30, 691-696 (2009).
23. Naito, Y. & Yoshikawa, T. Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress. Free Radic. Biol. Med. 33, 323-336 (2002).
24. Laisney, V., Nguyen Van, C., Gross, M. S. & Frezal, J. Human genes for glutathione S-transferases. Hum. Genet. 68, 221-227 (1984).
25. Rowe, J. D., Nieves, E. & Listowsky, I. Subunit diversity and tissue distribution of human glutathione S-transferases: interpretations based on electrospray ionization-MS and peptide sequence-specific antisera. Biochem. J. 325(Pt 2), 481-486 (1997).
26. Suzuki, T., Coggan, M., Shaw, D. C. & Board, P. G. Electrophoretic and immunological analysis of human glutathione S-transferase isozymes. Ann. Hum. Genet. 51(Part 2), 95-106 (1987).
27. De Bruin, W. C., Wagenmans, M. J. & Peters, W. H. Expression of glutathione S-transferase alpha, P1-1 and T1-1 in the human gastrointestinal tract. Jpn. J. Cancer Res. 91, 310-316 (2000).
28. La Torre, G., Boccia, S. & Ricciardi, G. Glutathione S-transferase M1 status and gastric cancer risk: a meta-analysis. Cancer Lett. 217, 53-60 (2005).
29. You, W. C., Hong, J. Y., Zhang, L., Pan, K. F., Pee, D., Li, J. Y. et al. Genetic polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the risk of advanced precancerous gastric lesions in a Chinese population. Cancer Epidemiol. Biomarkers Prev. 14, 451-458 (2005).
30. Kesarwani, P., Singh, R. & Mittal, R. D. Association of GSTM3 intron 6 variant with cigarette smoking, tobacco chewing and alcohol as modifier factors for prostate cancer risk. Arch. Toxicol. 83, 351-356 (2009).
31. Jain, M., Kumar, S., Lal, P., Tiwari, A., Ghoshal, U. C. & Mittal, B. Role of GSTM3 polymorphism in the risk of developing esophageal cancer. Cancer Epidemiol. Biomarkers Prev. 16, 178-181 (2007).
32. Jourenkova-Mironova, N., Mitrunen, K., Bouchardy, C., Dayer, P., Benhamou, S. & Hirvonen, A. High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers. Cancer Res. 60, 534-536 (2000).
33. Holley, S. L., Rajagopal, R., Hoban, P. R., Deakin, M., Fawole, A. S., Elder, J. B. et al. Polymorphisms in the glutathione S-transferase mucluster are associated with tumour progression and patient outcome in colorectal cancer. Int. J. Oncol. 28, 231-236 (2006).
34. Schnakenberg, E., Breuer, R., Werdin, R., Dreikorn, K. & Schloot, W. Susceptibility genes: GSTM1 and GSTM3 as genetic risk factors in bladder cancer. Cytogenet. Cell. Genet. 91, 234-238 (2000).
35. Mitrunen, K., Jourenkova, N., Kataja, V., Eskelinen, M., Kosma, V. M., Benhamou, S. et al. Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer Epidemiol. Biomarkers Prev. 10, 229-236 (2001).
36. Yengi, L., Inskip, A., Gilford, J., Alldersea, J., Bailey, L., Smith, A. et al. Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res. 56, 1974-1977 (1996).
37. Lan, Q., Chow, W. H., Lissowska, J., Hein, D. W., Buetow, K., Engel, L. S. et al. Glutathione S-transferase genotypes and stomach cancer in a population-based case-control study in Warsaw, Poland. Pharmacogenetics 11, 655-661 (2001).
38. Koivisto, T. T., Voutilainen, M. E. & Farkkila, M. A. Effect of smoking on gastric histology in Helicobacter pylori-positive gastritis. Scand. J. Gastrienterol. 43, 1177-1183 (2008).
39. Nakamura, M., Haruma, K., Kamada, T., Mihara, M., Yoshihara, M., Sumioka, M. et al. Cigarette smoking promotes atrophic gastritis in Helicobacter pylori-positive subjects. Dig. Dis. Sci. 47, 675-681 (2002).
40. Maity, P., Biswas, K., Roy, S., Banerjee, R. K. & Bandyopadhyay, U. Smoking and the pathogenesis of gastroduodenal ulcer-recent mechanistic update. Mol. Cell. Biochem. 253, 329-338 (2003).